Cargando…

The prevention and treatment of missing data in clinical trials /

"Randomized clinical trials are the primary tool for evaluating new medical interventions. Randomization provides for a fair comparison between treatment and control groups, balancing out, on average, distributions of known and unknown factors among the participants. Unfortunately, these studie...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores Corporativos: National Research Council (U.S.). Panel on Handling Missing Data in Clinical Trials, National Research Council (U.S.). Committee on National Statistics
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press, ©2010.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 EBOOKCENTRAL_ocn709748250
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cnu---unuuu
008 110329s2010 dcua ob 000 0 eng d
010 |a  2012405185 
040 |a N$T  |b eng  |e pn  |c N$T  |d COF  |d YDXCP  |d VPI  |d OCLCQ  |d DKDLA  |d OCLCQ  |d OCLCF  |d OCLCA  |d NLGGC  |d OCLCO  |d EBLCP  |d OCLCQ  |d OCLCO  |d DEBSZ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d VT2  |d TOA  |d AGLDB  |d ZCU  |d MERUC  |d U3W  |d BUF  |d STF  |d VNS  |d OCLCQ  |d VTS  |d EZ9  |d ICG  |d SNN  |d AU@  |d OCLCO  |d OCLCQ  |d MERER  |d UKMGB  |d WYU  |d TKN  |d OCLCO  |d U3G  |d DKC  |d OCLCQ  |d M8D  |d OCLCO  |d UKAHL  |d OCLCQ  |d OCLCA  |d AJS  |d OCLCO  |d OCLCQ  |d OCLCO  |d INARC  |d OCLCQ 
016 7 |a 101555711  |2 DNLM 
016 7 |a 015788695  |2 Uk 
019 |a 701903244  |a 764551233  |a 768695437  |a 771170675  |a 961562952  |a 962626512  |a 1028810694  |a 1051642071  |a 1055319679  |a 1063398053  |a 1064757268  |a 1081229055  |a 1156326310  |a 1204384650  |a 1228621617  |a 1249240334  |a 1412646099 
020 |a 9780309158152  |q (electronic bk.) 
020 |a 030915815X  |q (electronic bk.) 
020 |z 0309158141 
020 |z 9780309158145 
029 1 |a AU@  |b 000054178073 
029 1 |a DEBBG  |b BV043152549 
029 1 |a DEBBG  |b BV044109170 
029 1 |a DEBSZ  |b 421636238 
029 1 |a DEBSZ  |b 449741923 
029 1 |a GBVCP  |b 803551320 
029 1 |a UKMGB  |b 015788695 
035 |a (OCoLC)709748250  |z (OCoLC)701903244  |z (OCoLC)764551233  |z (OCoLC)768695437  |z (OCoLC)771170675  |z (OCoLC)961562952  |z (OCoLC)962626512  |z (OCoLC)1028810694  |z (OCoLC)1051642071  |z (OCoLC)1055319679  |z (OCoLC)1063398053  |z (OCoLC)1064757268  |z (OCoLC)1081229055  |z (OCoLC)1156326310  |z (OCoLC)1204384650  |z (OCoLC)1228621617  |z (OCoLC)1249240334  |z (OCoLC)1412646099 
050 4 |a R853.C55  |b N387 2010eb 
060 4 |a 2011 C-574 
060 4 |a WA 950 
072 7 |a HEA  |x 032000  |2 bisacsh 
072 7 |a MED  |x 034000  |2 bisacsh 
072 7 |a HEA  |x 009000  |2 bisacsh 
072 7 |a OCC  |x 011000  |2 bisacsh 
082 0 4 |a 615.50724  |2 22 
049 |a UAMI 
110 2 |a National Research Council (U.S.).  |b Panel on Handling Missing Data in Clinical Trials. 
245 1 4 |a The prevention and treatment of missing data in clinical trials /  |c Panel on Handling Missing Data in Clinical Trials, Committee on National Statistics, Division of Behavioral and Social Sciences, National Research Council of the National Academies. 
260 |a Washington, D.C. :  |b National Academies Press,  |c ©2010. 
300 |a 1 online resource (xv, 144 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references (pages 115-122). 
505 0 |a Introduction and background -- Trial designs to reduce the frequency of missing data -- Trial strategies to reduce the frequency of missing data -- Drawing inferences from incomplete data -- Principles and methods of sensitivity analyses -- Conclusions and recommendations. 
520 |a "Randomized clinical trials are the primary tool for evaluating new medical interventions. Randomization provides for a fair comparison between treatment and control groups, balancing out, on average, distributions of known and unknown factors among the participants. Unfortunately, these studies often lack a substantial percentage of data. This missing data reduces the benefit provided by the randomization and introduces potential biases in the comparison of the treatment groups. Missing data can arise for a variety of reasons, including the inability or unwillingness of participants to meet appointments for evaluation. And in some studies, some or all of data collection ceases when participants discontinue study treatment. Existing guidelines for the design and conduct of clinical trials, and the analysis of the resulting data, provide only limited advice on how to handle missing data. Thus, approaches to the analysis of data with an appreciable amount of missing values tend to be ad hoc and variable. The Prevention and Treatment of Missing Data in Clinical Trials concludes that a more principled approach to design and analysis in the presence of missing data is both needed and possible. Such an approach needs to focus on two critical elements: (1) careful design and conduct to limit the amount and impact of missing data and (2) analysis that makes full use of information on all randomized participants and is based on careful attention to the assumptions about the nature of the missing data underlying estimates of treatment effects. In addition to the highest priority recommendations, the book offers more detailed recommendations on the conduct of clinical trials and techniques for analysis of trial data."--Publisher's description. 
588 0 |a Print version record. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Clinical trials  |x Statistical methods. 
650 0 |a Experimental design. 
650 1 2 |a Randomized Controlled Trials as Topic  |x statistics & numerical data 
650 2 2 |a Biomedical Research  |x standards 
650 2 |a Research Design 
650 6 |a Études cliniques  |x Méthodes statistiques. 
650 6 |a Plan d'expérience. 
650 7 |a HEALTH & FITNESS  |x Alternative Therapies.  |2 bisacsh 
650 7 |a MEDICAL  |x Healing.  |2 bisacsh 
650 7 |a HEALTH & FITNESS  |x Healing.  |2 bisacsh 
650 7 |a BODY, MIND & SPIRIT  |x Healing  |x General.  |2 bisacsh 
650 7 |a Clinical trials  |x Statistical methods  |2 fast 
650 7 |a Experimental design  |2 fast 
710 2 |a National Research Council (U.S.).  |b Committee on National Statistics. 
776 0 8 |i Print version:  |a National Research Council (U.S.). Panel on Handling Missing Data in Clinical Trials.  |t Prevention and treatment of missing data in clinical trials.  |d Washington, D.C. : National Academies Press, ©2010  |z 9780309158145  |w (OCoLC)658581393 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3378730  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36617298 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36559433 
938 |a EBL - Ebook Library  |b EBLB  |n EBL3378730 
938 |a EBSCOhost  |b EBSC  |n 354522 
938 |a YBP Library Services  |b YANK  |n 3753768 
938 |a Internet Archive  |b INAR  |n preventiontreatm0000nati 
994 |a 92  |b IZTAP